Axis Securities has brought out its ‘Yearly Technical Outlook’ for the year 2025. In the document it has written at length ...
Cytokinetics is advancing aficamten, a potential competitor to Camzyos, targeting hypertrophic cardiomyopathy. Read my CYTK ...
Key areas of buyer interest include retail media, streaming TV, influencer marketing, and AI, industry insiders say.